Under Big Biotech's Wing

Like other major biotechnology companies, Biogen Idec Inc. has a cadre of talented scientists working feverishly to discover breakthrough drugs. Over the years, the Cambridge biotech has also made acquisitions, established a $105 million venture fund and licensed promising technologies to build a pipeline of potential life-saving therapies.
Boston.com